CEREBELLAR TUMOUR

CEREBELLAR TUMOUR was reported 126 times

These drug classes are most commonly taken by patients reporting CEREBELLAR TUMOUR:

# Drug Count
0 Nucleoside Metabolic Inhibitor [EPC] 30
1 Corticosteroid [EPC] 22
2 Folate Analog Metabolic Inhibitor [EPC] 20
3 Topoisomerase Inhibitor [EPC] 20
4 Alkylating Drug [EPC] 9
5 Kinase Inhibitor [EPC] 9
6 Estrogen Receptor Antagonist [EPC] 8
7 Angiotensin 2 Receptor Blocker [EPC] 6
8 Tumor Necrosis Factor Blocker [EPC] 6
9 Nonsteroidal Anti-inflammatory Drug [EPC] 5
10 Platinum-based Drug [EPC] 5
11 Serotonin-3 Receptor Antagonist [EPC] 4
12 HER2/neu Receptor Antagonist [EPC] 3
13 Insulin Analog [EPC] 3
14 Interferon beta [EPC] 3
15 Interleukin-2 Receptor Blocking Antibody [EPC] 3
16 Janus Kinase Inhibitor [EPC] 3
17 Platelet Aggregation Inhibitor [EPC] 3
18 Programmed Death Receptor-1 Blocking Antibody [EPC] 3
19 Thiazide Diuretic [EPC] 3
20 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
21 Aminosalicylate [EPC] 2
22 Anti-epileptic Agent [EPC] 2
23 Aromatase Inhibitor [EPC] 2
24 CD20-directed Cytolytic Antibody [EPC] 2
25 Carbonic Anhydrase Inhibitor [EPC] 2
26 Endothelin Receptor Antagonist [EPC] 2
27 GLP-1 Receptor Agonist [EPC] 2
28 HMG-CoA Reductase Inhibitor [EPC] 2
29 Loop Diuretic [EPC] 2
30 Parathyroid Hormone Analog [EPC] 2
31 Purine Antimetabolite [EPC] 2
32 Recombinant Human Growth Hormone [EPC] 2
33 Vitamin B12 [EPC] 2
34 Vitamin C [EPC] 2
35 Vitamin D [EPC] 2
36 Actinomycin [EPC] 1
37 Aldosterone Antagonist [EPC] 1
38 Angiotensin Converting Enzyme Inhibitor [EPC] 1
39 Antimetabolite [EPC] 1
40 Atypical Antipsychotic [EPC] 1
41 Benzodiazepine [EPC] 1
42 Cardiac Glycoside [EPC] 1
43 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
44 Dietary Cholesterol Absorption Inhibitor [EPC] 1
45 Epidermal Growth Factor Receptor Antagonist [EPC] 1
46 Erythropoiesis-stimulating Agent [EPC] 1
47 Expectorant [EPC] 1
48 Factor Xa Inhibitor [EPC] 1
49 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
50 Histamine-1 Receptor Antagonist [EPC] 1
51 Integrin Receptor Antagonist [EPC] 1
52 Interleukin-1 Receptor Antagonist [EPC] 1
53 Interleukin-17 Receptor A Antagonist [EPC] 1
54 Interleukin-23 Antagonist [EPC] 1
55 Interleukin-6 Receptor Antagonist [EPC] 1
56 Leukotriene Receptor Antagonist [EPC] 1
57 Nucleoside Analog Antiviral [EPC] 1
58 Osmotic Laxative [EPC] 1
59 Phenothiazine [EPC] 1
60 Phosphodiesterase 3 Inhibitor [EPC] 1
61 Phosphodiesterase 5 Inhibitor [EPC] 1
62 Potassium Salt [EPC] 1
63 Programmed Death Ligand-1 Blocker [EPC] 1
64 Prostacycline Vasodilator [EPC] 1
65 Proton Pump Inhibitor [EPC] 1
66 Provitamin D2 Compound [EPC] 1
67 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
68 Soluble Guanylate Cyclase Stimulator [EPC] 1
69 Tetracycline-class Drug [EPC] 1
70 Thalidomide Analog [EPC] 1
71 Thiazide-like Diuretic [EPC] 1